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Atherosclerosis is a chronic progressive disease, which develops from the moment 
of birth. Lipid deposit in blood vessel intima leads to gradual stenosis and impeding 
blood flow through tissues and eventually results in broad spectrum of clinical 
manifestations. Clinical manifestations are the consequence of plaque rupture which 
induce thrombogenesis and formation of thr o m b u s  a n d  e m b o l u s .  I n  t h i s  w a y ,  t h e  
process of thrombogenesis is followed by obstruction of blood vessels. Elimination of risk 
factors such as obesity, hyperlipidemia and hypertension improves endothelial function 
and reduces progression of atherosclerosis. Acta Medica Medianae 2007;46(1):25-29. 
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Introduction 
 
Atherosclerosis is diffuse, disseminated pa-
thological process affecting all vascular beds and 
is characterized by thickness and lipid deposition 
in intima of the blood vessel wall. Atherosclerotic 
plaque represents intima lipid accumulation and 
wall thickness. It primarily develops in intima of 
abdominal aorta, in its big branches, arteries for 
low extremities as well as coronary and cerebral 
arteries. It is characterized by accumulation of 
extracellular and intracellular lipids, monocyte/ 
macrophage infiltration, formation of foamy cells, 
proliferation of smooth muscle cells and accumu-
lation of fibrous-tissue proteins.  
Atherosclerosis can be clinically manifested 
as: coronary heart disease (angina pectoris, in-
farction, sudden heart death), cerebrovascular 
disease (transient ishemic attack- TIA, stroke) 
and periphery vascular disease (intermittent 
claudication, gangrene). 
 
Risk factors for atherogenesis 
 
All risk factors for atherosclerosis can be 
divided into modifying and non-modifying. Recent 
investigation has shown that besides the most 
important traditional risk factors (dyslipidemia, 
hypertension, cigarette smoking and diabetes 
mellitus) there are also non-traditional or modern 
risk factors such as (increased oxidative stress, 
endothelial dysfunction and inflammation (1). 
In spite of the fact that many pathogenic 
factors are included in pathogenesis of athero-
sclerosis, dyslipidemia still plays a central role in 
this process. Dyslipidemia stands for disorders in 
lipid concentration and composition. It results in 
disturbance of concentration of certain lipids 
(hyperlipidemia, hypercholesterolemia, hyperlipo-
proteinemia). Hyperlipidemia is the main cause of 
atherosclerosis and its related diseases, cardio-
vascular diseases, ischemic cerebrovascular dise-
ases and periphery vascular diseases. The most 
important risk factors for atherosclerosis are: 
increased LDL-C, decreased HDL-C, tobacco smo-
king, hypertension, diabetes mellitus type 2, old 
age, positive family anamnesis for cardiovascular 
disease in first line relatives (men under 55 years 
of age, women under 65 years of age) (2, 3). 
The firs link between cholesterol and athe-
rosclerosis was established in 1841, when Vogel 
demonstrated the presence of cholesterol in 
atherosclerotic plaque. In 1884, Von Rokitanski 
propounded thrombogenetic theory, and in 1856 
there emerged Virchov’s response theory stating 
that endothelium damage was a basis for further 
inflammation and cell proliferation. In 1913, Anit-
schkov and Chalotov demonstrated that nutrition 
rich in cholesterol induced atherosclerotic chan-
ges. Similarly, Goldstein and Brown identified 
LDL particles as main atherogenic lipoproteins.  
Numerous studies determined the key im-
portance of lipid disorders in atherogenesis and 
that the risk of cardiovascular diseases was 
significantly lower if LDL-C was under 4,2 mmol/l 
even if other risk factors were present. Combi-
nations of risk factors increase the risk of endo-
thelial dysfunction and incidence of myocardial 
infarction (3, 4). 
Cholesterol as a lipid represents the consti-
tuent part of cell membrane and it has a very 
important role in the synthesis of steroid hormo-
nes. Organism is provided with cholesterol in two 
ways: by cholesterol biosynthesis in the liver or 
by food intake. If organism receives more cho-
lesterol, decreased synthesis in the liver will 
occur. Other cells may not synthesize cholesterol, 
since they obtain it from plasma. In body liquids, 
cholesterol is carried out by hylomicrones, low 
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density lipoproteins (LDL) and high density lipo-
proteins (HDL) particles. Hylomicrones transport 
triglycerides, cholesterol and other lipids from 
intestine to liver and fatty tissue. LDL particles 
transfer cholesterol to periphery tissue, and HDL 
particles transfer excessive cholesterol from 
periphery tissue to liver. Since peripheral cells 
cannot synthesize cholesterol, LDL is the main 
source of cholesterol. Mechanism of cholesterol 
removal from LDL has its basis in LDL receptor 
which is present on the cell surface. LDL binds to 
specific receptor, thus inducing internalization, 
i.e. LDL is transferred into cytosol by endocy-
tosis, in the form of endocyte vesicle. It is taken 
by lysosomes and lysosome enzymes release 
cholesterol for cells needs. Released, uneste-
rificated cholesterol may be used for membrane 
biosynthesis, or if it is not needed temporarily it 
may be esterificated and deposited in the cell 
until it is needed again.  
Family hypercholesterolemia is a result of 
mutation only in one locus. The consequence is 
disturbed expression of LDL receptor. In homo-
zygotes, complete dysfunction of LDL receptors 
occurs, so that they very early die of progressive 
form of atherosclerosis. In heterozigotes there is 
one half of dysfunctional LDL receptors. Since 
LDL receptors do not have normal LDL function, 
cholesterol increases concentration in blood, 
which is associated with deposit in the wall and 
development of atherosclerosis.  
HDL lipoproteins have well-established pro-
tective effect. The basis of this effect is reverse 
transport of cholesterol. HDL transports choles-
terol from periphery tissues toward liver. HDL 
particles also contain antioxidative enzymes (PAF-
acetil-hydrolasis and paraoxonase) which break 
oxidated LDL particles down and neutralize their 
proinflammatory effect. Besides, they inhibit expre-
ssion of certain adhesive molecules (VCAM-1) (3). 
Hypertrigliceridemia may cause the change 
of structural cell membranes and activation of 
adenil-cyclase with the development of oxidative 
stress in endothelial cells, monocytes and lym-
phocytes. Also, aggregation and adhesion of 
thrombocytes as well as proliferation of smooth 
muscle cells is stimulated.  
An independent factor for the development 
of atherosclerosis is increased concentration of 
Lp(a) in blood plasma as a consequence of 
increased oxidation and easy penetration of this 
lipoprotein particles into blood vessel intima.  
Correction of hyperlipidemia presents si-
multaneous prevention and treatment of athe-
rosclerosis and its consequences. Therapy of 
hyperlipidemia decreases mortality of cardio-
vascular diseases by 30-40% as well as incidence 
of non-fatal events (1,3). Hypertension, also, 
represents another important factor for the 
development of atherogenesis. There is activation 
of renin-angiotensin system (RAS) in a great 
number of hypertensive patients. Activation of 
RAS with AT II formation and subsequent acti-
vation of AT II receptors, mostly of AT type I, is 
included in the process of atherogenesis. Angio-
tensin II increases expression of inflammatory 
factors such as P-selectin and monocyte chemo 
attractant protein (MCP-1), which regulate adhe-
sion of monocyte and other inflammatory cells. It 
also increases uptaking of ox-LDL and cholesterol 
biosynthesis in macrophages transferring them 
into foamy cells. It also increases gene activity 
for LOX-1 in culture of coronary endothelium. It 
leads to increase of apoptosis in human endo-
thelial cells, activity of nicotineamid dinucleotide 
phosphate (NADPH) oxidasis in macrophages, 
and NADPH oxidase increases oxidative stress. 
Mechanical wall stress is the main characteristic 
of arterial hypertension, which leads to activation 
of NADPH oxidase in smooth muscle cells and 
consequently to oxidative stress.  
Hypertension and hyperlipidemia as great 
risk factors for coronary disease are very often 
associated in many patients. Numerous studies 
r e v e a l e d  t h a t  A T  I I  a n d  o x - L D L  d o  n o t  a c t  
independently in the process of atherogenesis. 
These factors have the following common charac-
teristics: they lead to formation and release of 
free radicals; they neutralize and decrease expre-
ssion of endothelial N oxide synthetasis, which 
influences decrease of endothelium-dependent 
vasodilatation; they induce activation of redox 
sensitive transcription of nuclear factor kappa 
B(NF- kB); they have proinflammatory properties 
(they induce expression of adhesion molecules 
and cytokines, upregulation of gene for monocyte 
chemoattractant protein-1 and induce monocyte 
adhesion and apoptosis. 
Experimental studies have shown that 
hyperlipidemia increases RAS activity. There is 
linear correlation between concentration of LDL 
cholesterol in plasma and expression of AT I 
receptor (4). 
Hyperglycemia in diabetes increases oxi-
dative stress, thus contributing to vascular dys-
function. It influences endothelial dysfunction by 
production of free radicals, by sorbitol accumu-
lation, by non-enzyme glycolisation of macro-
molecules, and by direct activation of protein 
kinase C. Glycolisation of protein and lipids runs 
in each patient with diabetes and irreversibly 
leads to long-term vascular dysfunction  In initial 
protein glycolisation, early glycoside products are 
produced. Reorganization of molecules occurs 
later on, partially by oxidation and final glycoside 
products are produced (AGE) which react with 
superficial receptors thus producing free radicals 
and decreasing the level of reduced glutathione 
and activating redox sensitive transcription of 
factors NF-kB. In diabetics, oxidative modification 
of LDL particles occurs in circulation in contrast to 
non-diabetics in whom it is usually the wall of 
blood vessel, because there is enough amount of 
antioxidants in circulation. Produced AGE LDL 
particles lead to expression of VCAM-1 and 
monocyte-endothelial interaction with formation 
of atherosclerotic lesions (5). 
The World Health Organisation (WHO) and 
expert team of National Cholesterol Education 
Program Adult Treatment Panel (NCEP ATP III) 
defined metabolic syndrome as a new secondary 
target in therapy and reduction of cardiovascular 
diseases (5, 6). Acta Medica Medianae 2007,Vol.46  Pathogenetic aspects of atherosclerosis 
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Definition of metabolic syndrome implies the 
presence of at least three of the following para-
meters: waist circumference >102 cm in man and 
>88 cm in women; concentration of triglycerides 
(>1.7 mmol/l); HDL-C (<1 mmol/l in men and 
<1.3 in women); blood pressure (>130/85 
mmHg); fasting glycemia (>6.1 mmol/l). 
According to the WHO definition metabolic 
syndrome comprise one of the following disor-
ders: insuline resistention (HOMA > 2.5), -im-
paired glucose tolerance and DM type 2, plus two of 
the following disorders: hypertension (>140/90 
mmHg), body mass index (>30 kg/m
2), waist/hip 
ratio (>0.9 in men, >0.85 in women), 
triglyceride concentration (>1.7 mmol/l), HDL-C 
(<0.9 mmol/l in men, <1 mmol/l in women), 
albumine/creatinine ratio (>2.5 mg/mmol in 
men, > 3.5 mg/mmol in women). 
The importance of metabolic syndrome lies 
in the fact that there is concordance of many risk 
factors for the development of cardiovascular 
diseases. Moreover the metabolic syndrome has 
great prevalence in modern society. On the basis 
of WHO and NCEP ATP III criteria, it has be 
estimated that prevalence of metabolic syndrome 
in USA general population is 24%, while in 
population of elderly Americans over 60 years of 
age it is 44%.(7).  
Patients with metabolic syndrome are usually 
at very high risk for development of cardiovascu-
lar disease. Life style habits have great impact on 
all components of metabolic syndrome. There-
fore, one of the first actions in therapy of meta-
bolic syndrome shoud be modification of life style 
by losing weight and increased physical activity. 
It has been established that homocysteine 
has toxic effect on endothelial cells. Homocys-
teine (Hcy) is amino acid containing sulphate. It 
is not present in natural proteins because of the 
absence of DNA code for this amino acid. Total 
Hcy in organism is produced from metabolism of 
essential amino acid methionine. Hyperhomo-
cysteinemia is a name for higher concentrations 
of homocysteine in serum. Damaged endothelial 
cells enable better LDL penetration into suben-
dothelial space. Hyperhomocysteinemia higher 
than 100 micro mol/l is associated with early 
thrombosis and atherosclerosis. Various studies 
have shown that these patients have endothelial 
dysfunction and oxidative stress, but their effect 
has not been fully elucidated yet.  
Tobacco smoking significantly contributes 
to atherosclerosis of blood vessels. The fact that 
the system of prooxidants/antioxidants plays an 
important role in atherogenesis to some extent 
accounts for the significance of this risk factor in 
atherogenesis. Cigarettes contain a great number 
of prooxidants, which may directly influence the 
process of lipid peroxidation and decrease of 
antioxidant level. Also, they increase the level of 
peroxidation of LDL cholesterol and favors 
oxidation of LDL cholesterol (5,6,7,8). 
 
Atherogenesis and theory of oxidative 
change of LDL 
 
Atherogenesis represents production of 
atheromas (plaques made up of lipid nucleus 
surrounded by connective tissue), which is the 
main event of atherosclerosis. The basic me-
chanism for atheroma development and progre-
ssion is endothelial damage of blood vessels. 
Endothelial dysfunction initiates the whole sequ-
ence of successive reactions resulting in athero-
sclerotic lesion. Hereby, there exists direct rela-
tionship between risk factors for atherosclerosis 
(smoking, hyperlipidemia, hypertension, obesity, 
diabetes, inflammation, infection) and endothelial 
dysfunction. Immune system is directly involved 
in initiation of atherosclerosis playing a dominant 
role in the development of inflammatory reaction 
in plaque. Atherosclerosis morphologically begins 
by invisible endothelial dysfunction, which may 
be induced by physical, mechanical, chemical, 
toxic, infectious and immunological factors (1,9). 
There is great evidence that some patho-
genetic stimuli take part in the production of 
reactive oxidative particles in endothelial micro-
environment and that oxidative stress plays a 
key role in the development of endothelial dys-
function related to atherosclerosis. 
Oxidative stress is identified by process of 
atherosclerosis, which is an early stage of endo-
thelial dysfunction. With the development of athe-
rosclerotic process, a great amount of free ra-
dicals is produced, which further enforces athe-
rogenesis. Increased production of free radicals 
then influences four fundamental mechanisms of 
atherogenesis: LDL oxidation, dysfunction of 
endothelial cells and smooth muscle cells, growth 
and migration of monocytes (9). 
Risk factors for atherosclerosis such as 
hypertension and hyperlipidemia are associated 
with increased production of oxidative particles. A 
similar situation is present in diabetics and smo-
kers. Numerous cytokines, such as tumor ne-
crosis factor (TNF-), interferon (INF-9), interl-
eukines (IL-1, IL-6) and angiotensine II are of 
key importance in intracellular production of free 
radicals. High concentrations of low-density 
lipoproteins (LDL), particularly of oxidative form 
(ox-LDL), induce free radical production. The 
following growth factors have similar effects: 
thrombocyte risk factor (PDFG), epidermal 
growth factor (EFG) and vascular endothelial 
g r o w t h  f a c t o r  ( V E G F )  a s  w e l l  a s  h o r m o n e s  l i k e  
insulin (1,8,10). 
Atherogenic lesion primarily develops inside 
the blood vessel intima, starting from fat stripes 
and diffuse intima thickness, through fibrolipid 
plaque, up to developed lesions complicated by 
thrombosis, hemorrhage or calcified lesions 
(‘complicated lesions”). 
Oxidation of LDL particles, formation of fat 
stripes and proliferation of smooth muscle cells 
represent basis for formation of atheromatous 
fibrolipid plaque. A few cellular forms from 
arterial wall in the blood are included in the 
eterogenetic process:  endothelial cells, smooth 
muscle cells, macrophage, thrombocytes as well 
as numerous growth factors. Lipid theory 
hypothesis is based on increased integration and 
accumulation of LDL lipoprotein plasma in the 
blood vessel wall and their transformation into 
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Oxidation of LDL particles represents initial pro-
cess in the development of modified LDL forms, 
which are then ingested by macrophages. Oxi-
dative LDL modification (ox-LDL) has been lar-
gely investigated, and therefore, the valid theory 
has been named “peroxide theory of athe-
rogenesis). On predilection places for endothelial 
damage excess of circulated LDL is accumulated, 
resulting in endothelial damage manifestating 
with changes of permeability of endothelial 
barrier, procoagulant properties and release of 
vasoactive substances. Oxidatively modified LDL 
particles express chemotaxic effect on circulating 
monocytes as well as on T-Ly. Moreover, modi-
fied LDL lead to adhesion increase and aggre-
gation of monocytes and T-Ly, thus forming two 
adhesive molecules on the endothelial surface: 
vascular adhesive molecule-1 (VCAM-1) and 
intracellular adhesion molecule-1 (ICAM-1). It, 
also, causes release stimulation of monocyte 
chemotaxic protein from endothelial cells and 
additional monocyte mobilization from circulation. 
By chemotaxis, monocytes and T-Ly pass through 
endothelium and in subendothelial space are 
converted into macrophages, overtaking larger 
amount of modified LDL, transforming into foamy 
cells, which are a part of lipid nucleus of athe-
romas. It is considered that endothelial and smo-
oth muscle cells are capable of LDL modification 
by initiating process of lipid peroxidation, after 
which macrophages recognize and ingest modi-
fied LDL. LDL oxidation is followed by endothelial 
dysfunction and subsequently, by loss of 
endothelium-dependent vasodilatation, initiation 
of inflammatory response and aggravating of 
anticoagulant protection for the development of 
thrombosis (1,4,8,9). 
Macrophages may secrete oxidized LDL and 
superoxide anion which additionally damages en-
dothelium. Activated macrophages excrete nume-
rous risk factors (PDGF) stimulating proliferation 
of fibroblast and smooth muscle cells, TGF-R 
growth factor for smooth muscle cells. Trans-
formation of macrophages into foamy cells ena-
bles smooth muscle cells to be moved from 
media into intima where division, synthesis and 
secretion of connective tissue matrix take place. 
In this way, development of fibromuscular pro-
liferative lesion is enabled (4).  
 
Advanced lesions of atherosclerosis 
and its complications 
 
The first and most characteristic lesion of 
advanced atherosclerosis is atherosclerotic pla-
que consisting of lipids-rich core in central part of 
eccentrically thickened intima. The surface of the 
plaque toward lumen is covered by fibrous cap. 
The central part of the plaque is filled with lipid 
detritus which develops by increase and con-
fluence of small collections of extracellular lipids. 
Lipids (mainly, LDL) directly enter blood space by 
insudation from plasma or by macrophage endo-
cytosis, by means of scavenger receptor after 
oxidative modification and indirectly accumulated 
after necrosis of macrophages overfilled with 
lipids. Over time, the content of connective tissue 
(consisting of collagen and smooth muscle cells) 
is increased in the plaque (11). 
Increasing fibrolipid plaque is substrate for 
the development of thrombocytic complications. 
Relative relationship of nucleus size and conne-
ctive tissue is important to plaque prognosis. Big, 
eccentric lipid nucleus, great macrophage density 
and thin fibrous cap are risky to plaque rupture, 
thrombosis and acute coronary syndrome. 
In mature plaques, two main components in 
different relation are present: soft, atheromatous 
mash rich in lipids and hard sclerotic tissue rich 
in collagen. Sclerotic component is usually far 
more voluminous, it stabilizes plaque preven-ting 
it from disruption, while atheromatous mash des-
tabilizes plaque making it be prone to rupture. 
The main determinants of plaque vulnerability 
are the size and content of atheromatous core, 
thickness of fibrous cap, acute inflammation in-
side cap and cap stability.Predilection site for 
plaque rupture is edge region, where fibrous cap 
is the thinnest and infiltrated by macrophages. 
Desintegration of fibrous cap is followed by 
sudden exposure of highly thrombogenetic mash 
to blood flow. 
On previously ruptured plaque or intact 
plaque, sudden thrombosis may emerge due to 
the change in thrombocyte function, coagulation 
and/or fibrinolysis, which is probably important 
response mechanism for total occlusion of blood 
vessel and infarction. Harmful role of macro-
phages after plaque rupture reflects in induction 
of thrombine generation and luminal thrombosis 
by tissue factor. Tissue factor is integral mem-
brane protein, which binds to factor VII/VIIa and 
initiates coagulative cascade. It is overexpresed 
on the surface by lipids-overfilled with mono-
cytes, macrophages and foamy cells in human 
atherosclerotic lesions. Plaque rupture is also follo-
wed by development of hematoma through fib-
rous cap cleft, although particular hematomas 
may develop inside lesion due to hemorrhage 
from newly formed blood vessels. Mature plaq-
ues, particularly those containing greater amount 
of fibrous connective tissue, may calcify, whereby 
mineral deposits replace dead cells and extrace-
llular lipids. Advanced lesions are often associ-
ated with localized dilatation of the part of the 
blood vessel they occupy.  
Such aneurisms may contain mural throm-
bs, and particles of thrombi, which are dissemi-
nated into systemic circulation, may cause em-
bolia. Even if there are no complicated lesions, 
with the advancement of atherosclerosis the blo-
od vessel lumen becomes narrower, blood flow is 
disturbed and there is great risk of further dama-
ge of endothelial cells. In this way vicious circle is 
closed. Stenosis of lumen is followed by tissue 
hypoxia, and blood pressure is raised due to re-
duced elasticity of blood vessels. Thereby, there 
is a great possibility of the rupture of changed 
blood vessel wall and subsequent blood overflow 
into surrounding tissue, particularly under con-
dition of blood pressure increase (6,9). Acta Medica Medianae 2007,Vol.46  Pathogenetic aspects of atherosclerosis 
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Conclusion 
 
Atherosclerosis is a dynamic process cha-
racterized by significant changes in artery biology 
due to chemodynamic changes caused by growth 
and disruption of plaque. Disturbed vascular bio-
logy associated with atherosclerosis and its risk 
factors includes vasomotoric dysfunction and pla-
que inflammation as well as prothrombous/anti-
fibinolytic state. 
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PATOGENETSKI ASPEKTI ATEROSKLEROZE 
 
Mirjana Bakić 
 
 
Ateroskleroza je hronična bolest sa progresivnim tokom čiji razvoj praktično 
počinje od rođenja. Osnovni supstrat aterosklerotske lezije je deponovanje lipida u 
intimu krvnog suda, što dovodi do postupnog suženja i otežanog protoka krvi kroz tkiva. 
Kliničke manifestacije aterosklerotskog procesa su brojne i pre svega zavise od stepena 
suženja i brzine nastanka stenoze. Najčešće kliničke manifestacije su posledica rupture  
aterosklerotskog plaka što aktivira proces trombogeneze i dovodi do razvoja začepljenja 
krvnih sudova. Uklanjanje faktora rizika, kao što su gojaznost, hiperlipidemija, 
hipertenzija, dovodi do popravljanja endotelne disfunkcije i usporavanja patogeneze 
aterosklerotskog plaka. Acta Medica Medianae 2007;46(1):25-29. 
 
Ključne reči: ateroskleroza, faktori rizika, evolucija plaka 